Mark Sieczkarek
2017
In 2017, Mark Sieczkarek earned a total compensation of $1.6M as Chairman of the Board and CEO at NovaBay Pharmaceuticals, a 24% decrease compared to previous year.
Compensation breakdown
| Bonus | $33,000 |
|---|---|
| Option Awards | $1,113,105 |
| Salary | $440,000 |
| Other | $14,377 |
| Total | $1,600,482 |
Sieczkarek received $1.1M in option awards, accounting for 70% of the total pay in 2017.
Sieczkarek also received $33K in bonus, $440K in salary and $14.4K in other compensation.
Rankings
In 2017, Mark Sieczkarek's compensation ranked 6,644th out of 14,666 executives tracked by ExecPay. In other words, Sieczkarek earned more than 54.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,644 out of 14,666 | 55th |
Division Manufacturing | 2,458 out of 5,770 | 57th |
Major group Chemicals And Allied Products | 792 out of 2,074 | 62nd |
Industry group Drugs | 611 out of 1,730 | 65th |
Industry Pharmaceutical Preparations | 482 out of 1,329 | 64th |
Source: SEC filing on April 18, 2018.
Sieczkarek's colleagues
We found four more compensation records of executives who worked with Mark Sieczkarek at NovaBay Pharmaceuticals in 2017.